TAHL Cindy sold FATE Therapeutics Inc. ($FATE) shares on the open market twice in the last 365 days, totaling about $20,800. Her most recent sale occurred on January 9, 2026. These sales rank 11,016th among 11,678 individual insiders in the database by highest sold amount, compared to an average of $8.6 million per insider and about 6.4 transactions. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 15, 2026 | FATE THERAPEUTICS INC | $FATE | TAHL CINDY | See Remarks | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 118,998,693 | 9999.99% | 0.34% |
| Jan. 15, 2026 | FATE THERAPEUTICS INC | $FATE | TAHL CINDY | See Remarks | A | Common Stock | 100000 | $0.00 | 487,081.0000 | 118,998,693 | 25.83% | 0.08% |
| Jan. 9, 2026 | FATE THERAPEUTICS INC | $FATE | TAHL CINDY | See Remarks | S | Common Stock | 10589 | $1.06 | 387,081.0000 | 118,998,693 | 2.66% | 0.01% |
| Aug. 4, 2025 | FATE THERAPEUTICS INC | $FATE | TAHL CINDY | See Remarks | S | Common Stock | 9037 | $1.06 | 397,670.0000 | 113,685,177 | 2.22% | 0.01% |
| Jan. 15, 2025 | FATE THERAPEUTICS INC | $FATE | TAHL CINDY | See Remarks | A | Common Stock | 70000 | $0.00 | 406,707.0000 | 113,685,177 | 20.79% | 0.06% |
| Jan. 15, 2025 | FATE THERAPEUTICS INC | $FATE | TAHL CINDY | See Remarks | A | Stock Option (Right to Buy) | 275000 | $0.00 | 275,000.0000 | 113,685,177 | 9999.99% | 0.24% |
| Jan. 10, 2025 | FATE THERAPEUTICS INC | $FATE | TAHL CINDY | See Remarks | S | Common Stock | 5654 | $1.55 | 336,707.0000 | 113,685,177 | 1.65% | 0.00% |
| July 29, 2024 | FATE THERAPEUTICS INC | $FATE | TAHL CINDY | General Counsel and Secretary | A | Common Stock | 200000 | $0.00 | 342,361.0000 | 98,411,162 | 140.49% | 0.20% |
| Feb. 1, 2024 | FATE THERAPEUTICS INC | $FATE | TAHL CINDY | General Counsel and Secretary | A | Stock Option (Right to Buy) | 425000 | $0.00 | 425,000.0000 | 98,411,162 | 9999.99% | 0.43% |
| Jan. 9, 2024 | FATE THERAPEUTICS INC | $FATE | TAHL CINDY | General Counsel and Secretary | S | Common Stock | 10874 | $4.37 | 142,361.0000 | 98,411,162 | 7.10% | 0.01% |
| Nov. 9, 2023 | FATE THERAPEUTICS INC | $FATE | TAHL CINDY | General Counsel and Secretary | S | Common Stock | 24363 | $2.40 | 153,235.0000 | 0 | 13.72% | 0.00% |
| Feb. 6, 2023 | FATE THERAPEUTICS INC | $FATE | TAHL CINDY | General Counsel and Secretary | A | Stock Option (Right to Buy) | 425000 | $0.00 | 425,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 10, 2023 | FATE THERAPEUTICS INC | $FATE | TAHL CINDY | General Counsel and Secretary | S | Common Stock | 11553 | $5.24 | 177,598.0000 | 0 | 6.11% | 0.00% |